Key Highlights
- Third-quarter Revenue for Flyte Aviation (NYSEAMERICAN:VJET) reached USD 1,838 thousand in the period ended September 30, 2026, versus nothing in the same stretch of 2025.
- Net loss expanded to USD 15,121 thousand from USD 2,344 thousand, with a noncash USD 12.5 million write-down on Assets classed as held for sale.
- Continuing operations produced a USD 1,853 thousand loss, against USD 1,235 thousand in the year-earlier quarter.
- Cash and cash equivalents stood at USD 2,393 thousand, the Working Capital shortfall was USD 3.2 million, and the filing flags doubt about the Going Concern assumption.
How the FLYTE Deal Brings in Private Aviation Income
Flyte Aviation (NYSEAMERICAN:VJET) submitted its quarterly filing on November 16, 2026, covering the period to September 30, 2026. Before October 5, 2026 the Business traded as Catheter Precision, and that date brought both the new name and a move of its NYSE American symbol from VTAK to VJET. The first step was buying 19.98% of FLYTE from SEG Jets through a February 6, 2026 accord; the remaining 80.02% followed on March 9, 2026, and the two purchases together cost USD 14,753 thousand. FLYTE provides regional charter flights on leased Cirrus Vision aircraft and Brokers private jet trips out of Farmingdale, New York. Third-quarter sales were USD 1,838 thousand, direct costs were USD 1,514 thousand, and the remaining Gross Profit was USD 324 thousand. Sales for the nine months totalled USD 2,771 thousand, and one client supplied 14% of the quarter's revenue.
Write-Down of Held-for-Sale Cardiac Units Drives the Deficit
During September 2026 management moved its VIVO and LockeT cardiac operations into discontinued activities held for sale. Measuring that group at Fair Value minus disposal costs led to a noncash charge of roughly USD 12.5 million. The discontinued segment absorbed USD 13,268 thousand of losses in the quarter, pushing the overall shortfall to USD 15,121 thousand from USD 2,344 thousand twelve months earlier. Selling, general and administrative spending climbed to USD 2,780 thousand from USD 1,191 thousand, which left an operating Deficit of USD 2,456 thousand. Across nine months the net shortfall came to USD 20,117 thousand, versus USD 11,847 thousand previously.
Liquidity Is Thin, and the Auditor Flags Going-Concern Risk
Cash rose to USD 2,393 thousand on September 30, 2026, from USD 88 thousand at the end of 2025. Through common shares, Series C Convertible Preferred Stock and Warrant exercises, the company gathered roughly USD 18.7 million gross over nine months, yet operations used USD 10.2 million of cash. The accumulated deficit reached USD 329.6 million. In October, buyers also committed USD 2.05 million for Series C-4 Convertible Preferred Stock. The 1-for-10 reverse split that took effect on October 5, 2026 means per share data is presented on a restated basis.
Where Things Stand
Flyte Aviation (NYSEAMERICAN:VJET) recorded a USD 15.1 million quarterly deficit chiefly because former medical device units were marked down as the company repositioned toward private aviation. The roughly USD 12.5 million charge does not involve cash, and the continuing business lost a smaller USD 1,853 thousand. A non-binding letter of intent to dispose of the VIVO and LockeT units was signed on November 1, 2026, yet the filing does not guarantee that a transaction completes or spells out its value or schedule. Liquid funds were about USD 1.5 million on November 10, 2026, and management does not expect that sum to sustain operations. Goodwill of USD 12,161 thousand and intangibles of USD 4,038 thousand were kept on the books after a qualitative review detected no impairment.




![S&P/TSX Composite Index Spotlight: Canlan Ice Sports Corp. [TSX:ICE] — Small Cap Value Stock Stock in Focus Today](/featured_image/gallery/medium/shutterstock_2220328935_11_16_2026_15_29_24_212794.jpg)

Please wait processing your request...